Thursday Morning’s Market Insights: Chimerix Inc (CMRX) , Anavex Life Sciences Corp. (AVXL), Perion Network Ltd (PERI), Angie’s List Inc (ANGI)


Chimerix Inc (NASDAQ:CMRX) is up 5% in pre-market trading following news that Point 72 Asset Management showed a 5.3% stake in the company yesterday after market closed. Similarly, insider buying was also reported on the company, with directors Ernest Mario and Clarence Machado disclosing yesterday in a Form 4 filing that on December 29, 2015, they each bought 125,000 and 10,000 shares, respectively. According to TipRanks’ statistics, out of the 10 analysts who have rated the company in the last 3 months, 4 gave a Buy rating while 6 remain on the sidelines. The average 12-month price target for the stock is $17.38, marking a 108% upside from where shares last closed.

CMRX Consensus

Anavex Life Sciences Corp. (NASDAQ:AVXL) is down 6% in pre-market trading after Pomerantz Law Firm announced a filling of a class action lawsuit against the company. The law firm is accusing the company of making false or misleading claims regarding the company’s business. Specifically, the law firm is alleging that between May of 2013 and December of 2015, Anavex artificially inflated the share price through a stock promoter and issued false public statements. According to TipRanks’ statistics, 1 analyst rated the company in the past 3 months with a Buy rating and $15.00 price target, marking a 173% increase from where shares last closed.

AVXL Stats

Perion Network Ltd (NASDAQ:PERI) is up 4% in pre-market trading after the company updated its Q4 guidance earlier this morning. The company expects revenues of between $64 and $66 million for the quarter due to its acquisition of Undertone on November 30, 2015. Perion’s CEO Josef Mandelbaum stated, “Our mobile marketing platform has continued to show nice growth, and Undertone performed slightly better than expected in the month post acquisition.” According to TipRanks’ statistics, out of the 2 analysts who have rated the company in the past 3 months, both gave a Buy rating. The average 12-month price target for the stock is $5.00, marking a 35% upside from where shares last closed.

PERI Consensus

Angie’s List Inc (NASDAQ:ANGI) is up over 5% in pre-market trading this morning after owner Eric Semler filed a Form 4 with the SEC disclosing a transaction. On Monday, December 28, Semler purchased 98,124 shares of the stock. According to TipRanks’ statistics, out of the 6 analysts who have rated the company in the past 6 months, 1 gave a Buy rating while 5 remain on the sidelines. The average 12-month price target for the stock is $8.25, marking a 13% downside from where shares last closed.

ANGI Consensus